JW Shinyak Corp
KOSDAQ:067290
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
JW Shinyak Corp
KOSDAQ:067290
|
KR |
|
N
|
NC& Co Ltd
KOSDAQ:092600
|
KR |
|
Xinyi Solar Holdings Ltd
HKEX:968
|
CN |
Intrinsic Value
The intrinsic value of JW Shinyak Corp (067290) under the Base Case is 1 677.4 KRW per share. Compared with the current market price of 2 300 KRW, the stock appears Overvalued by 27% .
The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 0% a year over the next five years, after falling about 5% a year over the last five years. If revenue grew at its five-year pace of -5%, the estimate would be about ₩1,389.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What JW Shinyak Does
JW Shinyak is a South Korean pharmaceutical company that makes and sells medicines for hospitals and patients. Its product line includes prescription drugs and injectable treatments, along with sterile medical solutions such as IV fluids and other hospital-use formulations. The company’s main customers are hospitals, clinics, pharmacies, and drug distributors that buy these products for patient care.
- Headquarters
- Korea KR
- IPO date
- Feb 11, 2003
Revenue & Expenses Breakdown
JW Shinyak Corp
Earnings Waterfall
JW Shinyak Corp
The intrinsic value for JW Shinyak Corp (067290) under the Base Case is 1 677.4 KRW.
Compared with the current market price of 2 300 KRW, the stock appears Overvalued by 27% .